购物车
全部删除
您的购物车当前为空
CDK4-IN-3 (Compound 389) 是一种对细胞周期蛋白依赖性激酶 4 (CDK4) 具有高选择性的不可逆抑制剂 (IC50=25 nM),其对 CDK6 的选择性超过10倍。此化合物能够阻滞细胞周期于 G1 期,并诱导肿瘤细胞发生凋亡 (apoptosis)。CDK4-IN-3 有潜力用于乳腺癌、肺癌等实体瘤的研究。

CDK4-IN-3 (Compound 389) 是一种对细胞周期蛋白依赖性激酶 4 (CDK4) 具有高选择性的不可逆抑制剂 (IC50=25 nM),其对 CDK6 的选择性超过10倍。此化合物能够阻滞细胞周期于 G1 期,并诱导肿瘤细胞发生凋亡 (apoptosis)。CDK4-IN-3 有潜力用于乳腺癌、肺癌等实体瘤的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
CDK4-IN-3 相关产品
| 产品描述 | CDK4-IN-3 (Compound 389) is a highly selective irreversible inhibitor of cyclin-dependent kinase 4 (CDK4) with an IC50 of 25 nM and exhibits more than 10-fold selectivity over CDK6. It arrests the cell cycle at the G1 phase and induces apoptosis in tumor cells. CDK4-IN-3 holds potential for research in solid tumors such as breast and lung cancer. |
| 靶点活性 | CDK4:25 nM |
| 分子量 | 481.56 |
| 分子式 | C26H32FN5O3 |
| CAS No. | 3002399-75-6 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容